Kidney glomerular basement membranes (GBMs) originate in development from fusion of a dual basement membrane between endothelial cells and primitive epithelial podocytes. After fusion, segments of newly synthesized matrix, derived primarily from podocytes, appear as subepithelial outpockets and are spliced into GBMs during glomerular capillary loop expansion. To investigate GBM assembly further, we examined newborn mouse kidneys with monoclonal rat anti-mouse laminin IgGs (MAb) conjugated to horseradish peroxidase (HRP). In adults, these MAb strongly label glomerular mesangial matrices but bind only weakly or not at all to mature GBMs. In contrast, anti-laminin MAb intensely bound newborn mouse GBMs undergoing initial assembly. After intraperitoneal injection of MAb-HRP into neonates, dense binding occurred across both subendotheGa1 and subepithelial pre-fusion GMBs as well as forming mesangml matrices. Con-
Introduction
The glomerular capillary walls of mature kidneys are uniquely designed to provide a size-and charge-selective sieve of blood plasma. Peripheral glomerular capillary loops consist of a luminal fenestrated endothelial layer, a glomerular basement membrane (GBM), and an outer layer composed of interdigitating foot processes from visceral epithelial cells (podocytes) (16) . Axial areas between separate glomerular capillaries are occupied by smooth muscle-like mesangial cells, which are embedded in a mesangial matrix that is similar but not identical to the GBM (16). During initial formation of the glomerulus in developing kidneys, endothelial cells migrate into a groove that forms within comma-and S-shaped epithelial aggregates (derived from metanephric mesenchyme), and shortly thereafter primitive capillary loops are established (reviewed in 1,2,14,37). These early capillary loops contain two basement membranes, one beneath the endothelium and an adjacent, second basement membrane layer beneath developing epithelial podocytes (1-3,6,7,10,12,2 2,32,3 3,3 7,3 9,40). As the endothelial and epithe- lial cells continue to differentiate, the dual basement membrane appears to fuse, producing the GBM (2,32,37). During subsequent capillary expansion and glomerular maturation, additional basement membrane segments, derived primarily from podocytes, initially appear as subepithelial outpockets which are then spliced into the fused GBM (3,6). Exactly how basement membrane fusion and splicing occur is not known, but they may involve temporally regulated synthesis and secretion of matrix components and/or matrixdegrading enzymes (1).
A number of previous immunofluorescence and immunoelectron microscopic studies with polyclonal antibodies have localized laminin within developing and mature GBMs (1,14,16,37). Intravenous injections of affinity-purified anti-laminin-HRP, indirect post-embedding colloidal gold immunolabeling techniques, and labeling of frozen sections have all shown at the ultrastructural level that laminin is present throughout the GBM and mesangial matrix (3,4,6,13,16,23,28). In newborn rats, polyclonal anti-laminin IgGs also bind in linear patterns to the GBMs at all developmental levels including the subendothelial and subepithelial layers of prefusion stages and the subepithelial outpockets seen during splicing (3,6). In contrast to these results with polyclonal antibodies, we have shown previously that when rat anti-mouse laminin monoclonal IgGs (MAb) are intravenously injected into adult mice, several laminin epitopes appear absent or unaccessible in peripheral loop GBMs ( 5 ) . These epitopes are present, however, in mesangial matrices and in tubular basement membranes (5). Since others have also provided ultrastructural evidence showing that intravenously administered MAb to other GBM and podocyte antigens can permeate the adult GBM (11, 16, 23, 30) , the lack of GBM binding by injected anti-laminin MAb is probably not due to GBM barrier properties. Instead, we interpreted the absence of MAb binding to reflect heterogeneity in composition and structure between the GBM, mesangial matrix, and tubular basement membranes of mature kidneys ( 5 ) . In the studies presented here, we have used these antilaminin MAb to investigate the distribution of laminin in newborn mouse GBM. Intense labeling was seen in GBMs undergoing initial assembly but labeling rapidly diminished as glomeruli matured.
Materials and Methods
Animals and Reagents. Kidneys from 56 infant Balblc and C57BUJ6 mice and seven adult Balblc mice were used in these experiments. All injection and surgical procedures were in accordance with this institution's regulations for the care and use of laboratory animals and with those of the National Institutes of Health. Rat monoclonal anti-mouse Englebreth-Holm-Swarm (EHS) tumor laminin IgGs designated >Cl, 5D3, 8D3, and 9D2 were purified from ascites fluids obtained from nude mice and characterized as previously described ( 5 ) . Western blotting and rotary shadow electron microscopy have shown that the epitopes on laminin recognized by MAb 5C1, 8D3, and 9D2 are located towards the center of the laminin cross (5). In contrast. 5D3 binds near the terminal globular domain on the laminin long a i m (5). Polyclonal rabbit anti-laminin IgG was affiity-purified and characterized as detailed before (3,4). Chromatographically pure rat and rabbit IgGs were purchased 6rom CappeIl4rganon Teknika (Durham, NC).
Horseradish peroxidase (HRP) type VI, was obtained from Sigma (St Louis, MO). MAb and control rat IgG were conjugated directly to activated HRP by the method of Nakane and Kawaoi (31) .
Immunohistochemical Procedures. Since previous results have shown that epitopes recognized by these anti-laminin MAb are greatly affected by aldehyde fmtion (5). GBMs were labeled in vivo under normal blood flow conditions by IP injections of 0.15 ml into newborn mice, or IV injections of 0.3 ml into adults, of HRP-conjugated MAb, unconjugated MAb, or control rat IgG (1.5-2.0, mg IgGlml). Two hours to 28 days after injection, mice were anesthetized with ether and kidneys were removed. For immunofluorescence, unfixed kidneys were frozen in isopentane chilled in a dry ice-acetone bath and sectioned at -2O'C in a cryostat. Sections were air-dried, labeled with FITC-conjugated goat anti-rat IgG (Cappel Organon-Teknika), and then examined in a Leitz Aristoplan photomicroscope. For electron microscopy, kidneys were fixed for 5 min in situ by the subcapsular injection of 1.6% paraformaldehyde and 3% glutaraldehyde in 0.1 M sodium cacodylate buffer (21) . Strips of kidney cortex were incubated on ice for an additional 2 hr in the same fivative and tissue slices 40 wm thick were obtained with a Vibratome (Ted Pella; Redding, CA). Slices were then reacted for 45 min with freshly prepared 0.05% diaminobenzidine and 0.01% hydrogen peroxide (17) at pH 6.0 (35). After the peroxidase reaction, slices were post-fixed with 2% osmium, dehydrated, and embedded in epoxy resin. Ultra-thin sections were stained for 15-30 sec with lead citrate (34) and examined at 60-80 kV with a Hitachi H 7000 or JEOL 100 CX electron microscope.
A second immunofluorescence labeling approach involved the application of MAb or affinity-purified rabbit anti-laminin IgG (50 pg/ml) to cryostat sections of unfixed kidneys from mice that had not received Ab injections. After incubation with primary Ab, sections were washed and incubated with anti-rat IgG or goat anti-rabbit IgG (Cappel-Organon Teknika), as appropriate.
Results

Laminin Distribution in Glomeruli of Mature Mouse Kidneys
Injections of polyclonal rabbit anti-laminin IgG into adult mice resulted in brilliant linear labeling of peripheral loop GBMs as well as mesangial matrices (Figure la) , as shown previously (4). In contrast, when rat monoclonal anti-mouse laminin IgGs were injected into mature mice, variable GBM labeling was seen ( 5 ) . MAb 5D3 intensely bound to mesangial matrices, and narrow ribbons of faint immunoreactivity were also occasionally present in the GBMs of many peripheral capillary loops ( Figure Ib ). MAb 9D2, in contrast, bound only to mesangial matrices, and peripheral loop GBMs were generally negative ( Figure IC ). Identical labeling patterns were seen when unfixed kidneys taken from uninjected mice were sectioned in a cryostat and slides labeled sequentially with the MAb and secondary anti-rat Abs. In contrast, no labeling whatsoever was seen in mice that received IV injections of control rabbit or rat IgG, as shown previously (4,5). Similarly, cryostat sections incubated sequentially with control rat IgG and anti-rat IgG-FITC were completely negative.
Temporal Changes in Laminin Distribution in Developing Glomeruli
As seen in mature mice, when affinity-purified polyclonal rabbit anti-laminin IgG was injected into infant mice, GBMs and TBMs of nephrons in all stages of development were intensely labeled in linear patterns ( Figure 2 ). In contrast, the different anti-laminin MAbs produced variable immunolabeling patterns in kidneys of newborn mice, and these patterns changed as glomeruli matured (Figures 3a-3d ). In addition, for each particular MAb, immunofluorescence results obtained after MAb injection in vivo were exactly the same as those obtained after sequential labeling of cryostat sections of unfixed kidneys. However, injections of newborns with anti-laminin MAb or polyclonal Ab, under the conditions used here, did not lead to any pathological or ultrastructural alterations at any time point.
Early S-shaped Nephrons. MAb 5C1, 5D3, 8D3, and 9D2 all labeled basement membranes surrounding the early comma-and S-shaped nephron figures seen in subcapsular areas of infant kidneys ( Figures 3a-3d and 4) . In addition to identifying the forming tubule basement membranes, the MAb also bound in apparently large amounts to matrices in the vascular cleft of S-shaped nephrons, which is the site of initial glomerular development (Figures 3a, 3c , and 4).
Capillary Loop Stage Glomeruli. Although the early glomerular matrices of S-shaped nephrons were intensely labeled with all of the MAb, marked differences were seen in the slightly more advanced glomeruli undergoing capillary loop expansion. For example, only weak labeling of GBMs of forming glomerular capillary loops was seen with MAb 8D3, despite intense labeling of develop- Original magnification x 500. Bar = 40 pm.
ing Tl3Ms connected to the same nephron (Figure 3b ). On the other hand, immunofluorescence and immunoelectron microscopy showed that MAb 9D2 (Figure 3d ) and 5D3 ( Figure 5 ) bound abundantly and in apparently linear patterns to all GBMs as well as to mesangial matrices in capillary loop stage glomeruli. When capillary loop stage glomeruli of infant mice that had received IP injections of 5D3-HRP 24 hr before fixation were examined at higher magnification, both the subendothelial and subepithelial basement membrane layers were densely labeled throughout with peroxidase reaction product (Figure 5b ).
Maturing Glomeruli. The distributions of GBM-bound MAb 5C1, 5D3, and 9D2 also changed from the essentially linear patterns seen in capillary loop stage glomeruli to spotty, non-linear patterns in maturing stage glomeruli. As shown in Figure 3d , GBMs in capillary loop stage glomeruli were brightly and apparently uniformly labeled with injected 9D2, whereas those of maturing glomeruli in the same section fluoresced much less intensely. The forming mesangial matrices, on the other hand, were positive in glomeruli at all developmental stages, and mesangial staining became relatively more prominent in maturing glomeruli (Figure 3d ). Electron microscopy of kidneys from infant mice that had received IP injections of SC1-or 5D3-HRP 24 hr before fixation also showed heavy peroxidase deposition in mesangid matrices of maturing stage glomeruli ( Figure 6 ). Unlike the loose meshwork of extracellular material seen in forming mesangial areas of capillary loop stage glomeruli (Figure >a) , the mesangial matrices of maturing glomeruli appeared denser and were almost completely filled with HRP ( Figures 6 and 7) . However, the peripheral loop GBMs of maturing glomeruli were not uniformly labeled throughout with HRP, and intermittent lengths of reaction product were observed. In addition. much less peroxidase was seen in maturing GBM as compared with earlier staged glomeruli from the same animal (Figure 6 ; compare with Figures 5a and 5b) . The subepithelial outpockets of basement membrane commonly found in GBMs of maturing stage glomeruli were also generally negative for injected anti-laminin MAb (Figure 6 ). 
Disappearance of GBM-bound Anti-laminin MA6 with Glomerular Development
To test whether the observed absence of binding of injected antilaminin MAb to GBMs of maturing stage glomeruli might have been due to epitope masking during basement membrane assembly, MAb were injected IP into newborns and kidneys were removed 3 days to 2 weeks after injection. As shown in Figure 7 , the peripheral loop GBMs of maturing glomeruli contained only occasional short lengths of bound MAb-HRP. Two and 4 weeks after MAb injection, all peripheral loop GBMs in these young mice were either only very faintly labeled (5D3, Figure 8a ) or not labeled (9D2, Figure 8b ), in patterns that were extremely similar to MAb labeling seen in the fully mature glomeruli of adult mice (Figure 1) . In contrast to the GBMs, mesangial matrices of both young and adult animals contained large amounts of bound anti-laminin MAb (Figures 1. 7 , and 8 ).
cluding the double, pre-fusion GBMs of S-shaped and early capillary loop stage glomeruli, were immunoreactive for the anti-laminin MAb used in this study. As glomeruli matured, however, the binding of anti-laminin MAb to post-fusion GBMs decreased markedly.
Discussion
Several conclusions can be drawn from these experiments. First, all basement membranes of nephrons in early development, in- In contrast to GBMs, mesangial matrices remained intensely positive for anti-laminin MAb throughout glomerular development and maturation. Finally, exactly the same distribution pattems were observed irrespective of whether the MAb were delivered in vivo via the bloodstream or used in indirect labeling ex vivo on cryostat sections of unfixed kidneys. Taken together, the results point to three possible mechanisms that could account for the observed loss of GBM laminin immunoreactivity: (a) laminin epitopes may become masked or concealed during GBM fusion and splicing; (b) there may be relatively rapid replacement of one GBM laminin isoform with another; and (c) certain laminin epitopes may be conformationally altered or removed during the GBM assembly processes. As discussed below, we consider the latter two mechanisms to be more probable.
When polyclonal anti-laminin IgGs are intravenously injected into neonatal or adult rats and mice and kidneys are examined 1-24 hr after injection, intense linear labeling is seen throughout GBMs of all glomeruli (3,4,6). In addition, when kidneys from developing animals are inspected 4 days to 2 weeks after injection, many strips of densely labeled GBM are interspersed between unlabeled lengths (3,6). We have interpreted this result to reflect the splicing of newly synthesized (and therefore unlabeled) GBM into the labeled GBM already present ( 2~6 ) .
Hence, ifepitope masking were indeed occurring during GBM assembly, we would have expected at least some of the injected MAb bound to pre-fusion GBMs to have remained bound to lengths of post-fusion GBMs of maturing glomeruli. Within 3 days after injection, however, the injected MAb had been almost completely cleared from peripheral loop GBMs. In contrast, the mesangial matrices remained positive. Although the GBM-bound MAb could have been gradually released owing to a progressive loss of antibody affinity, the persistence of bound antibody within the mesangial matrix makes this possibility seem unlikely. Second, if epitope masking were occurring during GBM condensation and fusion, the presence of bound monoclonal or polyclonal anti-laminin IgGs could be anticipated to interfere with assembly and consequently to result in some structural GBM abnormalities. However, as shown here and earlier (3,6), neither fusion blockade, GBM thickening, nor other morphological defects have been observed in kidneys of neonatal animals that received single injections of anti-laminin Ab. In addition, we have also shown previously in mature kidneys that treatment of cryostat sections with acetic acid, heparinase, heparatinase, or chondroitinase ABC is unsuccessful in unmasking possibly cryptic GBM laminin epitopes ( 5 ) . Therefore, although we cannot completely exclude epitope masking, we do not believe that such a mechanism adequately explains the temporal changes we see in GBM immunolabeling patterns with anti-laminin MAb.
A number of recent studies have documented sequential changes in basement membrane gene expression during kidney development. In particular, Northern analysis of fetal mouse kidneys has shown that the appearance of mRNAs coding for the laminin B1 and B2 chains occurs before synthesis of message for the A chain (27). Laminin A chain appears critical for epithelial transformation of nephrogenic mesenchyme (24), however, and occurs coordinately with synthesis of the a6 integrin subunit during early tubule formation (38). Also unlike the B chains, which continue to be synthesized into adulthood, laminin A chain expression is a tran-sient event and, once kidneys mature, little A-chain mRNA or protein is detected in glomerular endothelial cells and podocytes (15) . Other studies have also shown that mature kidney GBMs, but not TBMs, contain the S chain of laminin, which is a homologue of the B1 chain (19,36) . Evidence from several other immunolocalization experiments also indicates that the glomerular and various tubule basement membranes are structured differently and may contain unique mixtures of components (5,11,13,18,20) . Although the MAb used in the present study are domain rather than chain specific, the progressive loss in GBM immunostaining with most of the MAb could therefore reflect replacement of one laminin isoform with a different laminin molecule. What is not known, however, is how new laminin molecules would become intercalated within the GBM and how the old laminin would be removed.
Whereas the GBM appears to be assembled by the fusion of subendothelial and subepithelial matrices followed by the insertion of additional basement membrane segments derived from podocytes, the biochemical factors controlling these processes are not understood. Perhaps temporally and spatially regulated exuacellular proteases partially digest susceptible matrix proteins. Such partial digestion could enable new intermolecular associations (e.g., laminin-laminin or laminin-collagen) to occur and thereby promote basement membrane fusion and splicing. Although several specific extracellular matrix-and basement membrane-degrading enzymes are known (8,9) , no information is yet available on whether any of these proteases are active during glomerular development. Nevertheless, we believe that our evidence is consistent with the possibility that proteolytic processing of basement membrane occurs during GBM assembly. Such processing could therefore result in an incremental loss or conformational change of certain laminin epitopes and therefore lead to a decrease in MAb binding. Previous immunouluasuuctural studies by others have also shown marked changes in the GBM distribution of the collagen a1 and a2 (IV) chains during glomerular maturation (12). Whereas both chains are seen abundantly throughout the early post-fusion GBMs of developing glomeruli, labeling decreases with maturation and becomes concentrated in subendothelial areas (12). Similarly, in studies to map the distribution of anionic sites in developing glomeruli, clusters of ruthenium red (33) and cationized ferritin (7) have been identified in pre-fusion GBMs in the laminae rarae interna and externa of the subendothelial and subepithelial basement layers, respectively, and in spaces between the two basement membranes. Once the two basement membranes fuse, however, anionic sites are not seen within the condensed lamina densa but are found only in the laminae rarae interna and externa (7,33). Recent immunofluorescence studies with MAb against the cellular form of fibronectin have also shown intense staining of the early GBM in vascular clefts of S-shaped nephrons but marked decreases in binding to capillary loop and maturing stage GBMs (26). Finally, several MAb against uncharacterized GBM antigens recognize fetal glomeruli but do not bind to mature GBMs (29).
Although much of the forgoing describes losses in GBM labeling coincident with glomerular development, there are also some cases in which epitopes not seen in early development are recognized with maturation. For example, certain peptides that may be related to the noncollagenous domain 1 (NC1) of the collagen a3 and a4 (IV) chains are first detected in the capillary loop and matur-ing stages of human kidney, which is well after the appearance of the NC1 domains of the a1 and a2 chains ( 2 5 ) . As discussed above for laminin, perhaps the appearance of a3 and a4 NC1 epitopes reflects the insertion of new collagen molecules into the GBM. Alternatively, extracellular proteases involved with GBM fusion and splicing might expose hidden epitopes on certain collagen chains.
In conclusion, we have documented the progressive loss of many laminin epitopes from the developing GBM but are uncertain how these losses occur. Although the decrease in binding of anti-laminin MAb may reflect epitope masking, we believe that more likely alternatives are the synthesis of new laminin isoforms, conformational changes, and/or proteolytic modification of extant laminin during GBM fusion and splicing. By whatever mechanism, however, the loss of laminin epitopes is restricted to the peripheral loop GBM and does not occur in mesangial matrices. This evidence further emphasizes the structural distinctions between the GBM and mesangial matrix and points to possibly different assembly processes as well.
